ketoconazole has been researched along with HIV Coinfection in 50 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine the efficacy and toxicity of two systemically active antifungal agents in the treatment of buccal and oesophageal candidiasis 111 HIV-infected patients with microscopically-confirmed candidiasis were randomized to receive either 200 mg itraconazole once a day or 200 mg ketoconazole twice a day for 28 days in a double blind study." | 5.07 | Itraconazole versus ketaconazole in the treatment of oral and oesophageal candidosis in patients infected with HIV. ( Allan, M; Connolly, GM; Gazzard, BG; Midgley, J; Smith, DE, 1991) |
| "A 46-year-old homosexual man with disseminated histoplasmosis and human immunodeficiency virus (HIV) infection had a histoplasmosis-related ulcerated verrucous plaque above his left upper lip; systemic and cutaneous disease manifestations of histoplasmosis resolved with daily ketoconazole therapy." | 3.68 | Disseminated histoplasmosis presenting as an ulcerated verrucous plaque in a human immunodeficiency virus-infected man. Report of a case possibly involving human-to-human transmission of histoplasmosis. ( Cohen, PR; Grossman, ME; Held, JL; Ross, MJ; Silvers, DN, 1991) |
| "Ketoconazole is a potent CYP3A inhibitor." | 2.74 | Drug-drug interaction study of ketoconazole and ritonavir-boosted saquinavir. ( Bour, F; Kaeser, B; Schmitt, C; Zandt, H; Zhang, X; Zwanziger, E, 2009) |
| "Oral candidiasis is one of the common diseases seen in HIV/AIDS patients." | 2.73 | Evaluation and treatment of oral candidiasis in HIV/AIDS patients in Enugu, Nigeria. ( Chukwuneke, F; Oji, C, 2008) |
| "Twelve HIV-infected patients were assigned into a one-sequence, two-period pharmacokinetic interaction study." | 2.73 | Effect of efavirenz on the pharmacokinetics of ketoconazole in HIV-infected patients. ( Jaruratanasirikul, S; Mahatthanatrakul, W; Ridtitid, W; Sriwiriyajan, S, 2007) |
| "Ketoconazole was investigated as a potential booster of once-daily (o." | 2.73 | Ketoconazole is inferior to ritonavir as an alternative booster for saquinavir in a once daily regimen in Thai HIV-1 infected patients. ( Autar, RS; Burger, DM; Cooper, DA; Hassink, E; Hill, A; Kimenai, E; Lange, JM; Phanuphak, P; Ruxrungtham, K; Sankote, J; Sutthichom, D; Wit, FW, 2007) |
| "When saquinavir was given together with rifampicin, exposure of saquinavir in terms of AUC0-8 h was decreased by 46% (95% CI: 18-65) compared with the baseline assessment." | 2.70 | The interaction of saquinavir (soft gelatin capsule) with ketoconazole, erythromycin and rifampicin: comparison of the effect in healthy volunteers and in HIV-infected patients. ( Bryson, H; Goggin, T; Grub, S; Jorga, K; Lüdin, E, 2001) |
| " Blood samples were collected over the daytime 12-hour dosing interval of the protease inhibitors at baseline (period 1, day 0) and after 10 days of coadministration of 200 mg (n = 6) or 400 mg (n = 6) of ketoconazole once daily (period 2, day 10)." | 2.69 | Effect of ketoconazole on ritonavir and saquinavir concentrations in plasma and cerebrospinal fluid from patients infected with human immunodeficiency virus. ( Cameron, DW; Gallicano, K; Khaliq, Y; Kravcik, S; Venance, S, 2000) |
| " In group 2, on 57 of 3316 days (2%), fluconazole in a higher dosage was administered for treatment." | 2.67 | Fluconazole prophylaxis of recurrent oral candidiasis in HIV-positive patients. ( Gentschew, G; Helm, EB; Just-Nübling, G; Meissner, K; Odewald, J; Staszewski, S; Stille, W, 1991) |
| " The topical agents are available in assorted dosage forms with varying degrees of efficacy and patient acceptability." | 2.39 | Treatment of oropharyngeal candidiasis in HIV-positive patients. ( Greenspan, D, 1994) |
| "When HIV patients with a malignancy need treatment with erlotinib, there is a potential of as-yet-undefined drug-drug interaction." | 1.39 | Ritonavir and efavirenz significantly alter the metabolism of erlotinib--an observation in primary cultures of human hepatocytes that is relevant to HIV patients with cancer. ( Beumer, JH; Christner, SM; Gramignoli, R; Parise, RA; Pillai, VC; Rudek, MA; Strom, SC; Venkataramanan, R, 2013) |
| "Ritonavir is a HIV protease inhibitor routinely prescribed to HIV patients that also potently inactivates cytochrome P4503A4 (CYP3A4), the major human drug-metabolizing enzyme." | 1.36 | Structure and mechanism of the complex between cytochrome P4503A4 and ritonavir. ( Poulos, TL; Sevrioukova, IF, 2010) |
| "Maraviroc is a substrate for CYP3A4, and exposure will therefore be modulated by CYP3A4 inhibitors." | 1.35 | Maraviroc: in vitro assessment of drug-drug interaction potential. ( Collins, C; Dickins, M; Hyland, R; Jones, B; Jones, H, 2008) |
| " Studies have suggested that ketoconazole, given in combination with saquinavir, increases the bioavailability of saquinavir." | 1.30 | The effectiveness of combined saquinavir and ketoconazole treatment in reducing HIV viral load. ( Jordan, WC, 1998) |
| "Histoplasmosis is a fungal infection caused by the organism Histoplasma capsulatum." | 1.29 | Oral histoplasmosis in HIV-infected patients. A report of two cases. ( Chernoff, DN; Chinn, H; Green, TL; Migliorati, CA; Silverman, S, 1995) |
| "Although blastomycosis is not an AIDS-defining infection, it may be reasonable to consider HIV testing and measurement of CD4 counts in patients with blastomycosis." | 1.29 | Blastomycosis and human immunodeficiency virus: three new cases and review. ( Abriola, KP; Greer, DL; Hernandez, RL; Hoadley, DJ; Witzig, RS, 1994) |
| "Data is summarized on six patients with allergic bronchopulmonary aspergillosis, all of whom improved on therapy, and twelve patients with histoplasmosis including eight with AIDS, eleven of whom responded (three newly reported cases are included)." | 1.28 | [The treatment of aspergillosis, cryptococcosis and histoplasmosis in immunocompromised patients. Report of experience in the United States]. ( Hostetler, JS; Stevens, DA, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (6.00) | 18.7374 |
| 1990's | 27 (54.00) | 18.2507 |
| 2000's | 16 (32.00) | 29.6817 |
| 2010's | 3 (6.00) | 24.3611 |
| 2020's | 1 (2.00) | 2.80 |
| Authors | Studies |
|---|---|
| Müller, FM | 1 |
| Staudigel, A | 1 |
| Salvenmoser, S | 1 |
| Tredup, A | 1 |
| Miltenberger, R | 1 |
| Herrmann, JV | 1 |
| Hasslocher-Moreno, AM | 1 |
| Sousa, AS | 1 |
| Xavier, SS | 1 |
| Mendes, FSNS | 1 |
| Nunes, EP | 1 |
| Grinsztejn, BGJ | 1 |
| Mediano, MFF | 1 |
| Darré, T | 1 |
| Saka, B | 1 |
| Mouhari-Toure, A | 1 |
| Djiwa, T | 1 |
| Pitché, P | 1 |
| Napo-Koura, G | 1 |
| Pillai, VC | 1 |
| Venkataramanan, R | 1 |
| Parise, RA | 1 |
| Christner, SM | 1 |
| Gramignoli, R | 1 |
| Strom, SC | 1 |
| Rudek, MA | 1 |
| Beumer, JH | 1 |
| Nadagir, SD | 1 |
| Chunchanur, SK | 1 |
| Halesh, LH | 1 |
| Yasmeen, K | 1 |
| Chandrasekhar, MR | 1 |
| Patil, BS | 1 |
| Oji, C | 1 |
| Chukwuneke, F | 1 |
| Hyland, R | 1 |
| Dickins, M | 1 |
| Collins, C | 1 |
| Jones, H | 1 |
| Jones, B | 1 |
| Kaeser, B | 1 |
| Zandt, H | 1 |
| Bour, F | 1 |
| Zwanziger, E | 1 |
| Schmitt, C | 1 |
| Zhang, X | 2 |
| Sevrioukova, IF | 1 |
| Poulos, TL | 1 |
| Clyti, E | 1 |
| Sayavong, K | 1 |
| Monchy, D | 1 |
| Chanthavisouk, K | 1 |
| Rincón, S | 1 |
| Cepero de García, MC | 1 |
| Espinel-Ingroff, A | 1 |
| Sriwiriyajan, S | 1 |
| Mahatthanatrakul, W | 1 |
| Ridtitid, W | 1 |
| Jaruratanasirikul, S | 1 |
| Autar, RS | 1 |
| Wit, FW | 1 |
| Sankote, J | 1 |
| Sutthichom, D | 1 |
| Kimenai, E | 1 |
| Hassink, E | 1 |
| Hill, A | 1 |
| Cooper, DA | 2 |
| Phanuphak, P | 1 |
| Lange, JM | 1 |
| Burger, DM | 1 |
| Ruxrungtham, K | 1 |
| Abel, S | 1 |
| Russell, D | 1 |
| Taylor-Worth, RJ | 1 |
| Ridgway, CE | 1 |
| Muirhead, GJ | 1 |
| Sekar, VJ | 1 |
| Lefebvre, E | 1 |
| De Pauw, M | 1 |
| Vangeneugden, T | 1 |
| Hoetelmans, RM | 1 |
| Chinn, H | 1 |
| Chernoff, DN | 1 |
| Migliorati, CA | 1 |
| Silverman, S | 2 |
| Green, TL | 1 |
| Johnson, EM | 1 |
| Warnock, DW | 1 |
| Luker, J | 1 |
| Porter, SR | 1 |
| Scully, C | 1 |
| Opocher, G | 1 |
| Mantero, F | 1 |
| Haug, C | 1 |
| Müller, F | 1 |
| Aukrust, P | 1 |
| Frøland, SS | 1 |
| Greenspan, D | 1 |
| Witzig, RS | 1 |
| Hoadley, DJ | 1 |
| Greer, DL | 1 |
| Abriola, KP | 1 |
| Hernandez, RL | 1 |
| Ficarra, G | 1 |
| Flaitz, CM | 1 |
| Gaglioti, D | 1 |
| Piluso, S | 1 |
| Milo, D | 1 |
| Adler-Storthz, K | 1 |
| Eversole, LR | 1 |
| Meyer, C | 1 |
| Wong, D | 1 |
| Shumack, S | 1 |
| Goller, MM | 1 |
| Cohen, PR | 2 |
| Duvic, M | 1 |
| Hamide, A | 1 |
| Dutta, TK | 1 |
| Vasireddy, S | 1 |
| Jordan, WC | 1 |
| Kantipong, P | 1 |
| Walsh, DS | 1 |
| Khaliq, Y | 1 |
| Gallicano, K | 1 |
| Venance, S | 1 |
| Kravcik, S | 1 |
| Cameron, DW | 1 |
| Smart, T | 1 |
| Grub, S | 1 |
| Bryson, H | 1 |
| Goggin, T | 1 |
| Lüdin, E | 1 |
| Jorga, K | 1 |
| Samaranayake, YH | 1 |
| Samaranayake, LP | 2 |
| Tsang, PC | 1 |
| Wong, KH | 1 |
| Yeung, KW | 1 |
| Anil, S | 1 |
| Ellepola, AN | 1 |
| Gallais, V | 1 |
| Lacour, JP | 1 |
| Ortonne, JP | 1 |
| Lafeuillade, A | 1 |
| Chaffanjon, P | 1 |
| Delbeke, E | 1 |
| Quilichini, R | 1 |
| Supparatpinyo, K | 1 |
| Chiewchanvit, S | 1 |
| Hirunsri, P | 1 |
| Uthammachai, C | 1 |
| Nelson, KE | 1 |
| Sirisanthana, T | 1 |
| Gallagher, PJ | 1 |
| Bennett, DE | 1 |
| Henman, MC | 1 |
| Russell, RJ | 1 |
| Flint, SR | 1 |
| Shanley, DB | 1 |
| Coleman, DC | 1 |
| Lewis, MA | 1 |
| Samaranyake, LP | 1 |
| Lamey, PJ | 1 |
| Smith, DE | 1 |
| Midgley, J | 1 |
| Allan, M | 1 |
| Connolly, GM | 1 |
| Gazzard, BG | 1 |
| Hostetler, JS | 1 |
| Stevens, DA | 1 |
| Schmidt-Westhausen, A | 1 |
| Schiller, RA | 1 |
| Pohle, HD | 1 |
| Reichart, PA | 1 |
| Andreo, JA | 1 |
| Vivancos, F | 1 |
| Serrano, P | 1 |
| Soriano, J | 1 |
| Just-Nübling, G | 1 |
| Gentschew, G | 1 |
| Meissner, K | 1 |
| Odewald, J | 1 |
| Staszewski, S | 1 |
| Helm, EB | 1 |
| Stille, W | 1 |
| Held, JL | 1 |
| Grossman, ME | 1 |
| Ross, MJ | 1 |
| Silvers, DN | 1 |
| Fish, DG | 1 |
| Ampel, NM | 1 |
| Galgiani, JN | 1 |
| Dols, CL | 1 |
| Kelly, PC | 1 |
| Johnson, CH | 1 |
| Pappagianis, D | 1 |
| Edwards, JE | 1 |
| Wasserman, RB | 1 |
| Clark, RJ | 1 |
| Barzilai, A | 1 |
| Sperling, RS | 1 |
| Hyatt, AC | 1 |
| Wedgwood, JF | 1 |
| Reidenberg, BE | 1 |
| Hodes, DS | 1 |
| Thorsen, S | 1 |
| Mathiesen, LR | 1 |
| Tindall, B | 1 |
| Hing, M | 1 |
| Edwards, P | 1 |
| Barnes, T | 1 |
| Mackie, A | 1 |
| Langford, A | 1 |
| Gelderblom, H | 1 |
| Reichart, P | 1 |
| McKnight, ML | 1 |
| Migliorati, C | 1 |
| Luangjarmekorn, L | 1 |
| Sererat, T | 1 |
| Taniguchi, K | 1 |
| Gallo, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Clinical Evaluation of Adjusted Doses of Darunavir/Ritonavir With Rifampicin in HIV-infected Volunteers[NCT03892161] | Phase 1 | 17 participants (Actual) | Interventional | 2018-04-12 | Terminated (stopped due to Risks to participation) | ||
| Vitamin D Status and T Cell Phenotype in HIV-infected Youth Supplemented With Cholecalciferol: a Randomized Clinical Trial.[NCT01656070] | Phase 2 | 50 participants (Actual) | Interventional | 2011-04-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 reviews available for ketoconazole and HIV Coinfection
| Article | Year |
|---|---|
Adrenal complications of HIV infection.
Topics: Acquired Immunodeficiency Syndrome; Adrenal Cortex; Adrenal Gland Diseases; AIDS-Related Opportunist | 1994 |
Treatment of oropharyngeal candidiasis in HIV-positive patients.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Candidiasis, Oral; CD4-Positive T- | 1994 |
Managing HIV. Part 5: Treating secondary outcomes. 5.1 HIV and skin disease.
Topics: Acyclovir; Antifungal Agents; Antiviral Agents; Dermatomycoses; Drug Eruptions; HIV Infections; Huma | 1996 |
[Cutaneous pigmentation disorders in human immunodeficiency virus infection].
Topics: Acquired Immunodeficiency Syndrome; Adrenal Insufficiency; Antiviral Agents; Bleomycin; Clofazimine; | 1992 |
Diagnosis and treatment of oral candidosis.
Topics: Antifungal Agents; Candidiasis, Oral; Chronic Disease; Fluconazole; HIV Infections; Humans; Immune T | 1991 |
11 trials available for ketoconazole and HIV Coinfection
| Article | Year |
|---|---|
Evaluation and treatment of oral candidiasis in HIV/AIDS patients in Enugu, Nigeria.
Topics: Acquired Immunodeficiency Syndrome; Administration, Topical; Adolescent; Adult; Aged; AIDS-Related O | 2008 |
Drug-drug interaction study of ketoconazole and ritonavir-boosted saquinavir.
Topics: Adult; Aged; Anti-HIV Agents; Antifungal Agents; Area Under Curve; Cross-Over Studies; Drug Interact | 2009 |
Effect of efavirenz on the pharmacokinetics of ketoconazole in HIV-infected patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Antifungal Agents; Area Unde | 2007 |
Ketoconazole is inferior to ritonavir as an alternative booster for saquinavir in a once daily regimen in Thai HIV-1 infected patients.
Topics: Adult; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Drug Administration Schedule; Fe | 2007 |
Effects of CYP3A4 inhibitors on the pharmacokinetics of maraviroc in healthy volunteers.
Topics: Adolescent; Anti-HIV Agents; Antifungal Agents; Atazanavir Sulfate; CCR5 Receptor Antagonists; Cyclo | 2008 |
Pharmacokinetics of darunavir/ritonavir and ketoconazole following co-administration in HIV-healthy volunteers.
Topics: Adolescent; Adult; Antifungal Agents; Area Under Curve; Cross-Over Studies; Darunavir; Dose-Response | 2008 |
Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis.
Topics: Antifungal Agents; Azoles; Candida albicans; Candidiasis, Oral; Drug Resistance, Microbial; Fluconaz | 1995 |
Effect of ketoconazole on ritonavir and saquinavir concentrations in plasma and cerebrospinal fluid from patients infected with human immunodeficiency virus.
Topics: Adult; Antifungal Agents; Dose-Response Relationship, Drug; Drug Interactions; Female; HIV Infection | 2000 |
The interaction of saquinavir (soft gelatin capsule) with ketoconazole, erythromycin and rifampicin: comparison of the effect in healthy volunteers and in HIV-infected patients.
Topics: Adult; Aged; Analysis of Variance; Anti-Bacterial Agents; Antifungal Agents; Area Under Curve; Biolo | 2001 |
Itraconazole versus ketaconazole in the treatment of oral and oesophageal candidosis in patients infected with HIV.
Topics: Antifungal Agents; Candidiasis; Candidiasis, Oral; Double-Blind Method; Esophageal Diseases; Female; | 1991 |
Fluconazole prophylaxis of recurrent oral candidiasis in HIV-positive patients.
Topics: Acquired Immunodeficiency Syndrome; Candidiasis, Oral; Chronic Disease; Drug Administration Schedule | 1991 |
34 other studies available for ketoconazole and HIV Coinfection
| Article | Year |
|---|---|
Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Azoles; Candida albicans; Candidiasis, Ora | 2007 |
Epidemiological-clinical profile and mortality in patients coinfected with Trypanosoma cruzi/HIV: experience from a Brazilian reference center.
Topics: Acquired Immunodeficiency Syndrome; Brazil; Chagas Disease; Coinfection; Female; HIV Infections; Hum | 2022 |
Basidiobolomycosis in Togo: clinico-pathological study of a series of 12 presumed cases.
Topics: Adult; Antifungal Agents; Entomophthorales; Female; HIV Infections; Humans; Ketoconazole; Male; Togo | 2018 |
Ritonavir and efavirenz significantly alter the metabolism of erlotinib--an observation in primary cultures of human hepatocytes that is relevant to HIV patients with cancer.
Topics: 14-alpha Demethylase Inhibitors; Adult; Aged; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; | 2013 |
Significance of isolation and drug susceptibility testing of non-Candida albicans species causing oropharyngeal candidiasis in HIV patients.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis, Oral; Drug Resistanc | 2008 |
Maraviroc: in vitro assessment of drug-drug interaction potential.
Topics: Area Under Curve; Atazanavir Sulfate; Cyclohexanes; Cytochrome P-450 CYP3A; Drug Interactions; HIV I | 2008 |
Structure and mechanism of the complex between cytochrome P4503A4 and ritonavir.
Topics: Binding Sites; Crystallography, X-Ray; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; He | 2010 |
[Penicilliosis in Laos].
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Female; HIV Infections; Humans; Ketoconazo | 2006 |
A modified Christensen's urea and CLSI broth microdilution method for testing susceptibilities of six Malassezia species to voriconazole, itraconazole, and ketoconazole.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Culture Media; Dermatomycoses; HIV Infecti | 2006 |
Oral histoplasmosis in HIV-infected patients. A report of two cases.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Histoplasmosis; HIV Infections; Humans | 1995 |
Subnormal serum concentration of 1,25-vitamin D in human immunodeficiency virus infection: correlation with degree of immune deficiency and survival.
Topics: Acquired Immunodeficiency Syndrome; Biopterins; Calcitriol; CD4-Positive T-Lymphocytes; Follow-Up St | 1994 |
Blastomycosis and human immunodeficiency virus: three new cases and review.
Topics: Adult; Blastomycosis; CD4 Antigens; CD4-CD8 Ratio; HIV Infections; HIV Seropositivity; Humans; Itrac | 1994 |
White lichenoid lesions of the buccal mucosa in patients with HIV infection.
Topics: Adult; Female; HIV Infections; Humans; Ketoconazole; Lichen Planus, Oral; Male; Mouth Mucosa; Zidovu | 1993 |
A banner year for AIDS therapy.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Antitubercular Agents; Atovaquone; HIV Inf | 1993 |
Lichen amyloidosis presenting as a papular pruritus syndrome in a human-immunodeficiency-virus-infected man.
Topics: Administration, Oral; Adult; Amyloidosis; Antifungal Agents; Emollients; Forearm; HIV Infections; Hu | 1997 |
Empirical treatment for PCP in HIV-infected patients--justified?
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antifungal Agents; HIV Infectio | 1995 |
The effectiveness of combined saquinavir and ketoconazole treatment in reducing HIV viral load.
Topics: Antifungal Agents; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Ketoc | 1998 |
Oral penicilliosis in a patient with human immunodeficiency virus in northern Thailand.
Topics: Adult; Antifungal Agents; Candidiasis, Oral; Female; HIV Infections; Humans; Ketoconazole; Mouth Dis | 2000 |
More clinical data on protease inhibitors.
Topics: Acquired Immunodeficiency Syndrome; CD4 Lymphocyte Count; Clinical Trials as Topic; Drug Resistance, | 1995 |
Heterogeneity in antifungal susceptibility of clones of Candida albicans isolated on single and sequential visits from a HIV-infected southern Chinese cohort.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Analysis of Variance; Antifungal Agent | 2001 |
Post-antifungal effect of polyene, azole and DNA-analogue agents against oral Candida albicans and Candida tropicalis isolates in HIV disease.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida; Candida albicans; | 2001 |
Maintenance itraconazole for visceral leishmaniasis in HIV infection.
Topics: Adult; Antifungal Agents; Female; HIV Infections; Humans; Itraconazole; Ketoconazole; Leishmaniasis, | 1992 |
Penicillium marneffei infection in patients infected with human immunodeficiency virus.
Topics: Adult; Amphotericin B; Antifungal Agents; Female; HIV Infections; Humans; Itraconazole; Ketoconazole | 1992 |
Reduced azole susceptibility of oral isolates of Candida albicans from HIV-positive patients and a derivative exhibiting colony morphology variation.
Topics: Candida albicans; Candidiasis, Oral; DNA, Fungal; Fluconazole; HIV Infections; Humans; Ketoconazole; | 1992 |
[The treatment of aspergillosis, cryptococcosis and histoplasmosis in immunocompromised patients. Report of experience in the United States].
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Cry | 1991 |
Oral Candida and Enterobacteriaceae in HIV-1 infection: correlation with clinical candidiasis and antimycotic therapy.
Topics: Administration, Topical; Adolescent; Adult; Antifungal Agents; Candida; Candidiasis, Oral; Drug Comb | 1991 |
[Visceral leishmaniasis with partial response to ketoconazole in a patient with positive antibodies to the human immunodeficiency virus].
Topics: Adult; Chronic Disease; HIV Infections; HIV Seropositivity; HIV-1; Humans; Ketoconazole; Leishmanias | 1991 |
Disseminated histoplasmosis presenting as an ulcerated verrucous plaque in a human immunodeficiency virus-infected man. Report of a case possibly involving human-to-human transmission of histoplasmosis.
Topics: Dermatomycoses; Histoplasmosis; HIV Infections; Humans; Ketoconazole; Lip; Male; Middle Aged | 1991 |
Coccidioidomycosis during human immunodeficiency virus infection. A review of 77 patients.
Topics: Adult; Amphotericin B; Arizona; California; Coccidioidomycosis; Dermatomycoses; Female; Follow-Up St | 1990 |
Mother to child transmission of human immunodeficiency virus 1 infection despite zidovudine therapy from 18 weeks of gestation.
Topics: Acyclovir; Adult; Diseases in Twins; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Human | 1990 |
Fluconazole for ketoconazole-resistant oropharyngeal candidiasis in HIV-1 infected patients.
Topics: Adult; Candidiasis, Oral; Drug Resistance, Microbial; Female; Fluconazole; HIV Infections; HIV-1; Hu | 1990 |
Severe clinical manifestations of primary HIV infection.
Topics: Adult; Candidiasis; CD4-Positive T-Lymphocytes; Esophageal Diseases; HIV Infections; Humans; Ketocon | 1989 |
Ultrastructural findings in oral hyperpigmentation of HIV-infected patients.
Topics: Adult; Cheek; Clofazimine; Female; Gingival Diseases; HIV Infections; Humans; Ketoconazole; Male; Me | 1989 |
Chemotherapeutic mouthrinses in immunocompromised patients.
Topics: Candida albicans; Candidiasis, Oral; Colony Count, Microbial; Drug Combinations; HIV Infections; Hum | 1989 |